Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-574-2 | CAS number: 68890-66-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No OECD Guideline study but according to accepted scientific standards at time of performance
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Radiolabelled [C14]-Octopirox was administered in aqueous polyethylene glycol to rats by oral intubation, intraperitoneal and subcutaneous
injection and its absorption and route and rate of excretion was examined by radiotracer and thin layer chromatography techniques. For topical
administration to evaluate skin penetration, [14C]-Octopirox was dissolved in an anionic shampoo base. - GLP compliance:
- yes
Test material
- Reference substance name:
- Octopirox
- IUPAC Name:
- Octopirox
- Reference substance name:
- Piroctone olamine
- IUPAC Name:
- Piroctone olamine
- Reference substance name:
- 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)
- EC Number:
- 272-574-2
- EC Name:
- 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)
- Cas Number:
- 68890-66-4
- Molecular formula:
- C14H23NO2.C2H7NO
- IUPAC Name:
- 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)
- Reference substance name:
- Octopirox-(pyridone-6[C14])-ethanolamine salt
- IUPAC Name:
- Octopirox-(pyridone-6[C14])-ethanolamine salt
Constituent 1
Constituent 2
Constituent 3
Constituent 4
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals were housed in separate plastic metabolism cages and fed with Spital pelleted diet and water ad libitum.
Administration / exposure
- Type of coverage:
- other: occlusive / non-occlusive
- Vehicle:
- other: anionic shampoo solution
- Duration of exposure:
- Defined exposure periods for skin penetration evaluations. Contact times ranging between 2.5 and 20 minutes. Experiments with and without rinse-off treatment.
- Doses:
- Stock solutions were used and diluted for testing. Aliquots were used for determination of the dose of [C14]-Octoriprox. Oral application amounted to approximately 4.8 mg per kg body weight.
- No. of animals per group:
- 12 rats (6 males and 6 females) divided into 3 groups of 2 males and 2 females each for oral, intraveneous and subcutaneous administration.
12 rats divided into 4 groups for analysing effect of occlusion and rinsing on skin penetration
12 rats divided into 4 groups for analysing effect of duration of contact on skin penetration
12 rats divided into 4 groups to analyse effect of test substance concentration on skin penetration
3 rats to analyse effect of hair on skin penetration
12 rats divided into 2 groups of 6 each to analyse blood and tissue levels of [C14]-Octopirox after dermal exposure without rinsing
12 rats divided into 2 groups of 6 each to analyse blood and tissue levels of [C14]-Octopirox after dermal exposure with rinsing - Control animals:
- no
- Details on study design:
- DOSE PREPARATION
- Method for preparation of dose suspensions:
Turnover study:
9.9 mg [14C]-Octopirox was dissolved in 2 drops of absolute ethanol and 8.5 mL of a 50% (v/v) distilled water solution of polyethylenglycol 200.
Skin penetration study:
As vehicle a proprietory shampoo without Octopirox containing 16% of the detergent sodium lauryl ether sulphate was used.
VEHICLE
- Justification for use and choice of vehicle (if other than water):
PEG 200 is a recommended vehicle. The shampoo base a normal carrier for typical use conditions.
TEST SITE
- Preparation of test site: 24 hours before treatment the hairs on the backs of the animals was clipped off
- Area of exposure: 10 cm2
- % coverage: 100
- Type of cover / wrap if used: non-occlusive as well as occlusive for comparison reasons
SITE PROTECTION / USE OF RESTRAINERS FOR PREVENTING INGESTION: yes: protective patches
REMOVAL OF TEST SUBSTANCE
- Removal of protecting device:
- Washing procedures and type of cleansing agent:
- Time after start of exposure:
SAMPLE COLLECTION
- Collection of blood:
- Collection of urine and faeces:
- Collection of expired air:
- Terminal procedure:
- Analysis of organs:
SAMPLE PREPARATION
- Storage procedure:
- Preparation details:
ANALYSIS
- Method type(s) for identification (e.g. GC-FID, GC-MS, HPLC-DAD, HPLC-MS-MS, HPLC-UV, Liquid scintillation counting, NMR, TLC)
- Liquid scintillation counting results (cpm) converted to dpm as follows:
- Validation of analytical procedure:
- Limits of detection and quantification:
OTHER:
Results and discussion
- Signs and symptoms of toxicity:
- no effects
- Dermal irritation:
- no effects
- Total recovery:
- Recovery of applied doses acceptable in the various experiments (details see study report)
Percutaneous absorption
- Dose:
- 2000 microgram
- Parameter:
- percentage
- Absorption:
- > 0.1 - < 1 %
- Remarks on result:
- other: 48 hours
Applicant's summary and conclusion
- Conclusions:
- Whether given by mouth, injection or application to the skin, Octopirox was excreted essentially unchanged. Based on the results of this study
systemic toxic effects of Octopirox due to absorption through the skin is negligible. - Executive summary:
Radiolabelled piroctone olamine was administered to rats in aqueous polyethylene glycol 200 solution, by oral intubation, intraperitoneal subcutaneous injection and its route and rate of excretion was examined by radiotracer methods. For topical treatment [14C]-piroctone olamine was dissolved in an anionic shampoo base and applied to rat skin.
When given by intubation or injection [C14]-Octopirox was excreted by the rat mostly in the faeces (65 – 85 % of the dose) with smaller amounts (6 – 19 %) in the urine. Most of excretion occurred within 24 hours of dosing.
Skin penetration of piroctone olamine at 1 % (w/v) in the shampoo without rinsing was 65.1 µg/cm2 under occlusive and 38.2 µg/cm2 under non-occlusive conditions. In a „rinse off“ treatment, penetration was reduced to 3.4 µg/cm2 under occlusive and 2.0 µg/cm2 under non-occlusive conditions. There was a dependence of skin penetration of piroctone olamine on duration of contact up to 10 minutes after application. . 48 hours after exposure, excretion was virtually complete.
Penetration increased significantly from 2.4 µg/cm2 after 2.5 minutes exposure to 45 µg/cm2 after 10 minutes duration of contact. There was no further increase in penetration of piroctone olamine at 20 minutes application of 1 % piroctone olamine in the shampoo. Skin penetration and deposition of piroctone olamine were both proportional to the piroctone olamine concentration between 0.1 and 1 % (w/v). Skin penetration increased from 0.31 to 3.6 µg/cm2while deposition increased from 0.8 to 7.6 µg/cm2. There was no significant difference between the penetration through clipped skin and hairy skin from an application of 1 % piroctone olamine for 5 minutes followed by rinsing.
Blood levels after topical application (15.4 mg/kg body weight) without rinsing and with occlusion reached 0.32 µg/ml at 6 hours. However, when the skin was rinsed and protected with a non-occlusive patch, blood levels were reduced to a maximum of 0.02 ug/ml at 1 hour after application.
Whether given by mouth, injection or application to the skin, piroctone olamine was excreted essentially unchanged. Based on the results, systemic effects of piroctone olamine due to absorption through the skin is negligible.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.